Analyst Research

Report Title Price
Provider: Sadif Analytics Prime
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

STAR Pharmaceutical Ltd Comments On Q4, FY 2012 Earnings Guidance


Friday, 18 Jan 2013 04:25am EST 

STAR Pharmaceutical Ltd announced that for fourth quarter 2012 and fiscal 2012, it expects to report a loss, financial results were adversely affected by a substantial write-off of an intangible asset of Category I Chinese Medicine Drug, Yanning Capsules, and allowance for impairment of deposit due to termination contract of R&D patent right acquisition. 

Latest Developments for STAR Pharmaceutical Ltd

Company Quote

0.068
 --
24 Dec 2014